BEIJING TIANTAN BIOLOGICAL PRODUCTS CO., LTD.

Andere Sprachen Beijing Tiantan Biological Products Co., Ltd.

Aktien

A0M36A

CNE000000WF9

600161

Schlusskurs Shanghai S.E. Andere Börsenplätze 00:00:00 28.05.2024			% 5 Tage	% 1. Jan.
27,98 ^CNY	-2,88 %		-3,98 %	-9,57 %

16.05.	Bank of China Executive Vice President tritt zurück	MT
02.05.	ICBC, CCB ernennen stellvertretende Parteisekretäre	MT

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Bank of China Executive Vice President Steps Down	16.05.
ICBC, CCB Name Deputy Party Secretaries	02.05.
Tiantan Biological Products' Q1 Profit Jumps 21%; Shares Rise 7%	12.04.
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	11.04.
Tiantan Biological Products Scraps Clinical Trial of Intravenous Cytomegalovirus Human Immunoglobulin	01.02.
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	10.01.
China Baoli Technologies Chairman Redesignated as Vice Chairman	30.11.
Didi Global Reports Q3 Revenue of RMB 51.4 Billion, Up 25% YoY	13.11.
DIDI- ON NOV 11, YI ZHANG RESIGNED AS DIRECTOR OF THE CO, CHEN S…	13.11.
Tiantan Biological Products Secures Another Blood Collection License	02.11.
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	25.10.23
Tiantan Biological Products' Profit Jumps 47.7% in First Three Quarters; Shares Up 5%	13.10.23
Tiantan Biological Products' Unit Gets Nod to Register Intravenous Human Immunoglobulin, Passes Regulatory Inspection	27.09.23
Beijing Tiantan Biological Products Co., Ltd.(XSSC:600161) added to S&P Global BMI Index	18.09.23
Beijing Tiantan Biological Products Co., Ltd.(XSSC:600161) added to FTSE All-World Index	18.09.23
Beijing Tiantan Biological Products Lands Blood Collection License in China’s Liping County	15.09.23
Tiantan Biological Unit Registers Blood Disorder Treatment; Shares Jump 4%	11.09.23
Tiantan Biological Products Secures Another Blood Plasma Collection License	07.09.23
Beijing Tiantan Biological Products Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	13.07.23
Tiantan Biological Products Gets License for Four Plasma Stations	27.06.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Beijing Tiantan Biological Products Co., Ltd.

Aktien

A0M36A

CNE000000WF9

600161

Andere Sprachen

Filter